The value of extended glioblastoma resection: Insights from randomized controlled trials.
作者信息
Gonda David D, Warnke Peter, Sanai Nader, Taich Zack, Kasper Ekkehard M, Chen Clark C
机构信息
Division of Neurosurgery, University of California, San Diego, CA, USA.
出版信息
Surg Neurol Int. 2013 Aug 28;4:110. doi: 10.4103/2152-7806.117173. eCollection 2013.
Abstract
摘要
相似文献
1
The value of extended glioblastoma resection: Insights from randomized controlled trials.
Surg Neurol Int. 2013 Aug 28;4:110. doi: 10.4103/2152-7806.117173. eCollection 2013.
2
The SAFE-trial: Safe surgery for glioblastoma multiforme: Awake craniotomy versus surgery under general anesthesia. Study protocol for a multicenter prospective randomized controlled trial.
Contemp Clin Trials. 2020 Jan;88:105876. doi: 10.1016/j.cct.2019.105876. Epub 2019 Oct 30.
3
A randomized controlled phase II trial of vaccination with lysate-loaded, mature dendritic cells integrated into standard radiochemotherapy of newly diagnosed glioblastoma (GlioVax): study protocol for a randomized controlled trial.
Trials. 2018 May 25;19(1):293. doi: 10.1186/s13063-018-2659-7.
4
Supramaximal resection: A systematic review of its safety, efficacy and feasibility in glioblastoma.
J Clin Neurosci. 2020 Feb;72:328-334. doi: 10.1016/j.jocn.2019.12.021. Epub 2019 Dec 18.
5
Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion.
Acta Neurochir (Wien). 2011 Jun;153(6):1211-8. doi: 10.1007/s00701-011-1001-x. Epub 2011 Apr 9.
6
Prognostic implications of resection extent for patients with glioblastoma multiforme: a meta-analysis.
J Neurosurg Sci. 2017 Dec;61(6):631-639. doi: 10.23736/S0390-5616.16.03619-5. Epub 2016 Jan 29.
7
Feasibility study of finalizing the extended adjuvant temozolomide based on methionine positron emission tomography (Met-PET) findings in patients with glioblastoma.
Sci Rep. 2019 Nov 28;9(1):17794. doi: 10.1038/s41598-019-54398-2.
8
Results of a multicenter survey showing interindividual variability among neurosurgeons when deciding on the radicality of surgical resection in glioblastoma highlight the need for more objective guidelines.
Clin Transl Oncol. 2017 Jun;19(6):727-734. doi: 10.1007/s12094-016-1598-6. Epub 2016 Dec 22.
9
Resection of recurrent glioblastoma multiforme in elderly patients: a pseudo-randomized analysis revealed clinical benefit.
J Neurooncol. 2020 Jan;146(2):381-387. doi: 10.1007/s11060-020-03393-z. Epub 2020 Jan 13.
10
Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials.
Int J Radiat Oncol Biol Phys. 1993 May 20;26(2):239-44. doi: 10.1016/0360-3016(93)90203-8.
引用本文的文献
1
A position- and time-dependent pressure profile to model viscoelastic mechanical behavior of the brain tissue due to tumor growth.
Comput Methods Biomech Biomed Engin. 2023 May;26(6):660-672. doi: 10.1080/10255842.2022.2082245. Epub 2022 May 31.
2
Association between medical academic genealogy and publication outcome: impact of unconscious bias on scientific objectivity.
Acta Neurochir (Wien). 2019 Feb;161(2):205-211. doi: 10.1007/s00701-019-03804-9. Epub 2019 Jan 23.
3
Quantification of glioblastoma mass effect by lateral ventricle displacement.
Sci Rep. 2018 Feb 12;8(1):2827. doi: 10.1038/s41598-018-21147-w.
4
A cerebrospinal fluid microRNA signature as biomarker for glioblastoma.
Oncotarget. 2017 Jun 1;8(40):68769-68779. doi: 10.18632/oncotarget.18332. eCollection 2017 Sep 15.
本文引用的文献
1
Levels of evidence in the neurosurgical literature: more tribulations than trials.
Neurosurgery. 2012 Dec;71(6):1131-7; discussion 1137-8. doi: 10.1227/NEU.0b013e318271bc99.
2
Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial.
Lancet Oncol. 2011 Oct;12(11):997-1003. doi: 10.1016/S1470-2045(11)70196-6. Epub 2011 Aug 23.
3
Awake surgery for WHO Grade II gliomas within "noneloquent" areas in the left dominant hemisphere: toward a "supratotal" resection. Clinical article.
J Neurosurg. 2011 Aug;115(2):232-9. doi: 10.3171/2011.3.JNS101333. Epub 2011 May 6.
4
Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion.
Acta Neurochir (Wien). 2011 Jun;153(6):1211-8. doi: 10.1007/s00701-011-1001-x. Epub 2011 Apr 9.
5
An extent of resection threshold for newly diagnosed glioblastomas.
J Neurosurg. 2011 Jul;115(1):3-8. doi: 10.3171/2011.2.jns10998. Epub 2011 Mar 18.
6
Intraobserver and interobserver agreement in volumetric assessment of glioblastoma multiforme resection.
Neurosurgery. 2010 Nov;67(5):1329-34. doi: 10.1227/NEU.0b013e3181efbb08.
7
Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias.
Neurosurgery. 2008 Mar;62(3):564-76; discussion 564-76. doi: 10.1227/01.neu.0000317304.31579.17.
8
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.
Lancet Oncol. 2006 May;7(5):392-401. doi: 10.1016/S1470-2045(06)70665-9.
9
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
N Engl J Med. 2005 Mar 10;352(10):987-96. doi: 10.1056/NEJMoa043330.
10
Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.
J Neurosurg. 2003 Sep;99(3):467-73. doi: 10.3171/jns.2003.99.3.0467.
Zotero 插件